DK1400246T3 - Orale sammensætninger til behandling af adipöse, ikke-diabetiske pattedyr, indbefattet mennesker - Google Patents

Orale sammensætninger til behandling af adipöse, ikke-diabetiske pattedyr, indbefattet mennesker

Info

Publication number
DK1400246T3
DK1400246T3 DK02732763T DK02732763T DK1400246T3 DK 1400246 T3 DK1400246 T3 DK 1400246T3 DK 02732763 T DK02732763 T DK 02732763T DK 02732763 T DK02732763 T DK 02732763T DK 1400246 T3 DK1400246 T3 DK 1400246T3
Authority
DK
Denmark
Prior art keywords
obesity
including humans
mammals
diabetic
treatment
Prior art date
Application number
DK02732763T
Other languages
Danish (da)
English (en)
Inventor
De Barbara Ramon Gomis
Carles Marc Claret
Cirera Joan-Josep Guinovart
Alvarez Josefa Fernandez
Original Assignee
Quimica Farm Bayer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quimica Farm Bayer Sa filed Critical Quimica Farm Bayer Sa
Application granted granted Critical
Publication of DK1400246T3 publication Critical patent/DK1400246T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02732763T 2001-05-16 2002-05-16 Orale sammensætninger til behandling af adipöse, ikke-diabetiske pattedyr, indbefattet mennesker DK1400246T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101200A ES2187276B1 (es) 2001-05-16 2001-05-16 Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
PCT/ES2002/000231 WO2002098435A1 (es) 2001-05-16 2002-05-16 Composiciones orales para el tratamiento de mamíferos obesos y no diabéticos, incluyendo humanos

Publications (1)

Publication Number Publication Date
DK1400246T3 true DK1400246T3 (da) 2007-03-05

Family

ID=8497838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02732763T DK1400246T3 (da) 2001-05-16 2002-05-16 Orale sammensætninger til behandling af adipöse, ikke-diabetiske pattedyr, indbefattet mennesker

Country Status (11)

Country Link
US (1) US7122209B2 (de)
EP (1) EP1400246B1 (de)
AT (1) ATE344042T1 (de)
BR (1) BR0210975A (de)
CA (1) CA2447141A1 (de)
CY (1) CY1105975T1 (de)
DE (1) DE60215812T2 (de)
DK (1) DK1400246T3 (de)
ES (2) ES2187276B1 (de)
PT (1) PT1400246E (de)
WO (1) WO2002098435A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1972342A4 (de) * 2005-07-29 2011-01-12 Univ Barcelona Pharmazeutische zusammensetzungen aus einem wolframsalz (vi) zur behandlung von neurodegenerativen störungen, insbesondere alzheimer-krankheit und schizophrenie
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
CN100515428C (zh) * 2007-04-26 2009-07-22 暨南大学 钨酸锂在制药中的应用
ES2478790B1 (es) * 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
CA2955914C (en) * 2014-07-21 2022-09-06 Ignacio Canals Almazan Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025928A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 薬剤
DE4018513C1 (de) * 1989-12-20 1991-05-08 Karl Oexmann, Inh. Wolfgang Oexmann, 4650 Gelsenkirchen, De
US5192197A (en) * 1991-11-27 1993-03-09 Rockwell International Corporation Piezoelectric pump
CH689836A5 (fr) * 1994-01-14 1999-12-15 Westonbridge Int Ltd Micropompe.
US5611214A (en) * 1994-07-29 1997-03-18 Battelle Memorial Institute Microcomponent sheet architecture
US5595763A (en) * 1995-07-19 1997-01-21 Quimica Farmaceutica Bayer S.A. Tungsten (VI) compositions for the oral treatment of diabetes mellitus
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
US6148635A (en) * 1998-10-19 2000-11-21 The Board Of Trustees Of The University Of Illinois Active compressor vapor compression cycle integrated heat transfer device

Also Published As

Publication number Publication date
EP1400246B1 (de) 2006-11-02
WO2002098435A1 (es) 2002-12-12
DE60215812T2 (de) 2007-08-30
PT1400246E (pt) 2007-02-28
US20040131697A1 (en) 2004-07-08
CY1105975T1 (el) 2011-04-06
ES2187276A1 (es) 2003-05-16
DE60215812D1 (de) 2006-12-14
ES2187276B1 (es) 2004-08-01
BR0210975A (pt) 2004-10-05
US7122209B2 (en) 2006-10-17
ATE344042T1 (de) 2006-11-15
ES2275873T3 (es) 2007-06-16
EP1400246A1 (de) 2004-03-24
CA2447141A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
HRP20040308A2 (en) Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
NO20050294L (no) Nye forbindelser nyttige i behandlingen av fedme, type II diabetes og CNS forstyrrelser
WO2004067550A3 (fr) Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
RU2004110726A (ru) Применение оксинтомодулина, способ и фармацевтическая композиция для профилактики или лечения избыточной массы тела, способ снижения массы тела
WO2004052847A3 (en) Tricyclic steroid hormone nuclear receptor modulators
PT1465626E (pt) Composições farmacêuticas (kit) que compreendem compostos di-hidropiridinona e um agente imunorregulador (ou antiinflamatório) e suas utilizações
DK1417975T3 (da) Middel til behandling af sygdomme, med tab af knoglemasse som følge, med EP4-agonist som aktivt indholdsstof
BR0215151A (pt) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
DE69908397D1 (de) Betulinsäure derivate zur behandlung von neuroektodermalen tumoren
WO2000015205A3 (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
GB0102672D0 (en) Compounds
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
WO2002058692A3 (fr) Composition halogenee de hypohalites avec n-chloramine taurine, procede de preparation et ses utilisations
WO2002085853A3 (en) Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
CY1105975T1 (el) Στοματικες συνθεσεις για την θepαπεια παχυσαρκων, μη διαβητικων θηλαστικων, πepιλαμβανομενων των ανθρωπων
SE0303480D0 (sv) Benzofuranes
WO2003000173A3 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
BR0102211A (pt) Composição farmacêutica para o tratamento da obesidade ou para facilitar ou promover a perda de peso
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
BR9811293A (pt) Composições para o tratamento da alopecia, do hirsutismo feminino ou da seborréia, ou uma composição para a prevenção da metástase óssea causada por câncer prostático, e, usos de um composto e de n-{1-metil-1-(4-metoxifenil)etil}-3-oxo-4-aza-5-alfa-and rost-1-eno-17-beta-c arboxamida
ATE511395T1 (de) Mittel zur behandlung von glomerulopathie
DE50212971D1 (de) C2-disubstituierte indan-1-ol-systeme und ihre verwendung als arzneimittel